breast cancer

López JCV, Ho A, Hughes KS, Bardia A, Vidula N. Utilizing natural language processing (NLP) to identify breast cancer-associated lung metastases from pathology reports to[...]

By afschroeder • April 3, 2026

Daniel E, Young JR, Deng F, Patel SK, Sedrak MS, Kim H, Razavi M, Sun CL, Root JC, Ahles TA, Dale W, Chen BT. Alterations[...]

By afschroeder • March 28, 2026

Ji J, Crespi CM, Yee L, Zekster YA, Al-Saleem A, Petersen L, Lee C, Son N, Smith C, Evans T, Tchkonia T, Kirkland JL, Kuchel[...]

By afschroeder • March 16, 2026

Ramin C, Gresham G, Li J, Karlstaedt A, Hashibe M, Nikolova AP, Atkins KM. Cardiovascular disease mortality among women diagnosed with de novo metastatic breast[...]

By afschroeder • February 27, 2026

Afari H, Xia C, Mwita J, Moshomo T, Huang A, Shaikh M, Motlhwa SW, Ralefala T, Vuylsteke P, Dryden-Peterson S, Hsue PY, Gross R, Mosepele[...]

By afschroeder • January 23, 2026

Arega E, Dieli-Conwright CM, Yang EH. Defining the Name of the Game in Exercise Oncology: How Do We Incentivize Physical Activity? JACC CardioOncol. 2025 Dec;7(7):829-832.[...]

By afschroeder • January 18, 2026

Greene RK, Maghfour J, Nguyen C, Baker G, Mesinkovska NA. Association between hair dye use and human cancers: A systematic review. JAAD Int. 2025 Oct[...]

By afschroeder • December 16, 2025

Hammer PM, Enamandram S, Ikeda DM, Lam MM, Wapnir IL, Chamberlain ED, Shaheen S, Caswell-Jin JL, Itakura H, Bean GR. Mammary small cell neuroendocrine carcinomas[...]

By afschroeder • November 22, 2025

LeVee A, Kordic A, Ruel N, Mortimer J, Kang I, McArthur H, Lechner MG, Tsai K. Safety and Clinical Outcomes of Pembrolizumab Standard-Interval Dosing Versus[...]

By afschroeder • November 9, 2025

Li DX, Jarrett T, Ma J, Garcia JF. Anti-Ri Paraneoplastic Neurologic Syndrome in a Patient With Untreated Breast Cancer. Cureus. 2025 Sep 6;17(9):e91743. doi: 10.7759/cureus.91743.[...]

By afschroeder • October 8, 2025